MARKER THERAPEUTICS INC (MRKR)
US57055L2060 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 21.35M | 43.90M | |||
| Cash Equivalents | 15.11M | 11.78M | 42.35M | 21.35M | 43.90M | |||
| Receivables | 1.03M | 2.40M | 0.00 | 1.00M | 60.00K | |||
| Other Current Assets | 988.13K | 2.44M | 3.63M | 2.06M | 1.53M | |||
| Total Current Assets | 17.13M | 16.62M | 45.98M | 24.41M | 45.49M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 17.80M | 22.15M | 21.20M | 870.00K | |||
| Other Non-Current Assets | 0.00 | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 0.00 | 17.80M | 22.16M | 21.20M | 870.00K | |||
| TOTAL ASSETS | 17.13M | 34.42M | 68.14M | 45.61M | 46.36M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | N/A | 2.91M | 3.57M | 3.06M | 530.00K | |||
| Accounts Payable | 1.75M | 2.37M | 8.18M | 3.34M | 1.43M | |||
| Other Current Liabilities | 1.33M | 2.50M | 1.15M | 0.00 | 30.00K | |||
| Total Current Liabilities | 3.07M | 7.78M | 12.90M | 6.40M | 1.99M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 7.04M | 11.25M | 11.87M | 280.00K | |||
| Total Non-Current Liabilities | 0.00 | 7.04M | 11.25M | 11.87M | 280.00K | |||
| TOTAL LIABILITIES | 3.07M | 14.82M | 24.15M | 18.27M | 2.27M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -436.29M | -428.05M | -398.12M | -356.24M | -327.53M | |||
| Additional Paid In Capital | 450.33M | 447.64M | 442.02M | 383.53M | 371.57M | |||
| Common Shares | 8.89K | 10.00K | 80.00K | 50.00K | 50.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 8.90M | 8.40M | 8.31M | 5.07M | 4.57M | |||
| Tangible Book Value per Share | 1.58 | 2.33 | 5.29 | 5.39 | 9.65 | |||
| Total Shareholders' Equity | 14.05M | 19.60M | 43.99M | 27.34M | 44.09M | |||
| TOTAL LIABILITIES AND EQUITY | 17.13M | 34.42M | 68.14M | 45.61M | 46.36M | |||
| Statistics | ||||||||
| Current Ratio | 5.57 | 2.14 | 3.56 | 3.81 | 22.86 | |||
| Return On Assets (ROA) | -48.09% | -86.96% | -61.46% | -62.95% | -46.23% | |||
| Return On Equity (ROE) | -58.61% | -152.70% | -95.20% | -105.01% | -48.61% | |||
All data in USD